Dr Aldred’s research combines her wide-ranging experience in inherited diseases and cancer genetics to the study of PAH and Hereditary Hemorrhagic Telangiectasia (HHT). PAH is a potentially fatal disorder characterized by proliferative changes in the vessels of the lungs, leading to a sustained elevation in pulmonary artery pressure. 


  • Genetics of Pulmonary Hypertension and Hereditary Hemorrhagic Telangiectasia
  • Precision Health

Her work now focuses on characterizing the molecular basis for these changes and their functional role in the disease process.

PhD, MRC Human Genetics Unit, Edinburgh, 1993
BS, University College London, Genetics, 1988